TERF1 and lung carcinoma: To circumvent these potential shortcomings of telomerase inhibition, here we set out to address the therapeutic effect of acute telomere uncapping owing to Trf1 abrogation (Martinez et al, 2009) in the K-RasG12V lung cancer model (Guerra et al, 2003).